Physician profile
Elizabeth Lieberman
NPI 1578982567
$352,843.12
in general payments reported to CMS, 2019-2025
15 companies · $273K in 2025
The $273K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $470 · 2021: $499 · 2022: $15K · 2023: $25K · 2024: $39K · 2025: $273K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $313K · Travel and Lodging: $13K · Food and Beverage: $7,062 · Honoraria: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $313,221.25 |
| Travel and Lodging | $13,421.97 |
| Food and Beverage | $7,061.96 |
| Honoraria | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $274,829.41 | 2022-2025 | Persona, Rosa, Avenir |
| Medical Device Business Services, INC. | $54,026.41 | 2019-2025 | Actis, Velys, Kincise |
| Depuy Synthes Products, INC. | $9,823.50 | 2022-2024 | Velys, Kincise |
| Averitas Pharma INC. | $3,044.67 | 2024 | |
| Depuy Synthes Sales INC. | $2,741.14 | 2019-2024 | Attune, Actis, Na |
| Smith+Nephew, INC. | $2,455.84 | 2021-2023 | Journey II, Legion, Redapt |
| Ethicon INC. | $2,325.00 | 2024 | Stratafix, Dermabond Prineo |
| Steelhead Surgical INC | $1,200.00 | 2022 | |
| Brixton Biosciences, INC. | $1,000.00 | 2024 | Neural Ice |
| Stryker Corporation | $426.85 | 2020-2024 | Mako |
| Total Joint Orthopedics, INC. | $367.46 | 2022-2023 | |
| Medtronic USA, INC. | $300.49 | 2020 | |
| Acumed LLC | $205.87 | 2024 | Acumed, Montage 5cc |
| Biocomposites INC | $81.19 | 2020 | |
| Encore Medical, Lp | $15.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Lieberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.